Julie M. Cherrington's most recent trade in Mirati Therapeutics Inc was a trade of 7,520 Non Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 20, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 7,520 | 7,520 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2023 | 4,444 | 4,444 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 44.66 per share. | 18 Jan 2023 | 2,546 | 0 (0%) | 0% | 44.7 | 113,704 | Common Stock |
| Vaxart Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 37,280 | 37,280 | - | - | Stock Option (right to buy) | |
| Vaxart Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Aug 2022 | 6,217 | 6,217 (0%) | 0% | 0 | Common Stock | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 116.07 per share. | 19 Jan 2022 | 1,475 | 2,546 (0%) | 0% | 116.1 | 171,203 | Common Stock |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 3,688 | 3,688 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 2,546 | 4,021 (0%) | 0% | 0 | Common Stock | |
| Vaxart Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Aug 2021 | 65,700 | 65,700 | - | - | Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 201.00 per share. | 02 Mar 2021 | 1,990 | 1,485 (0%) | 0% | 201 | 399,990 | Common Stock |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Sale of securities on an exchange or to another person at price $ 203.00 per share. | 02 Mar 2021 | 10 | 1,475 (0%) | 0% | 203 | 2,030 | Common Stock |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 2,155 | 2,155 | - | - | Non Qualified Stock Option (right to buy) | |
| Mirati Therapeutics Inc | Julie M. Cherrington | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 1,475 | 3,475 (0%) | 0% | 0 | Common Stock |